Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

Davide Pareyson; Chiara Marchesi

doi:10.1016/s1474-4422(09)70110-3

journal article Jul 01, 2009

Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

Davide Pareyson

Chiara Marchesi

The Lancet Neurology Vol. 8 No. 7 pp. 654-667 · Elsevier BV

View at Publisher Save 10.1016/s1474-4422(09)70110-3

Topics

No keywords indexed for this article. Browse by subject →

References

121

[1]

Shy "Hereditary motor and sensory neuropathies: an overview of clinical, genetic, electrophysiologic and pathologic features" (2005)

[2]

Epidemiology of peripheral neuropathy.

C N Martyn, R A Hughes

Journal of Neurology, Neurosurgery &amp; Psych... 1997 10.1136/jnnp.62.4.310

[3]

Pareyson "Clinical and electrophysiological aspects of Charcot–Marie–Tooth disease" Neuromolecular Med (2006) 10.1385/nmm:8:1-2:3

[4]

Reilly "Sorting out the inherited neuropathies" Pract Neurol (2007)

[5]

Barisic "Charcot–Marie–Tooth disease: a clinico-genetic confrontation" Ann Hum Genet (2008) 10.1111/j.1469-1809.2007.00412.x

[6]

Jani-Acsadi "Charcot–Marie–Tooth neuropathies: diagnosis and management" Semin Neurol (2008) 10.1055/s-2008-1062264

[7]

Szigeti "Charcot–Marie–Tooth disease" Eur J Hum Genet (2009) 10.1038/ejhg.2009.31

[8]

Benedetti "Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy" J Neurol Neurosurg Psychiatry (2005) 10.1136/jnnp.2004.046110

[9]

Leal "Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models" Neurogenetics (2009) 10.1007/s10048-009-0213-1

[10]

Houlden "Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type" Neurology (2008) 10.1212/01.wnl.0000319696.14225.67

[11]

Pareyson "Axonal Charcot–Marie–Tooth disease: the fog is only slowly lifting" Neurology (2007) 10.1212/01.wnl.0000266399.43823.af

[12]

Scherer "Molecular mechanisms of inherited demyelinating neuropathies" Glia (2008) 10.1002/glia.20751

[13]

Krajewski "Neurological dysfunction and axonal degeneration in Charcot–Marie–Tooth disease type 1A" Brain (2000) 10.1093/brain/123.7.1516

[14]

Lupski "DNA duplication associated with Charcot–Marie–Tooth disease type 1A" Cell (1991) 10.1016/0092-8674(91)90613-4

[15]

Raeymaekers "Duplication in chromosome 17p11.2 in Charcot–Marie–Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group" Neuromuscul Disord (1991) 10.1016/0960-8966(91)90055-w

[16]

Nelis "Estimation of the mutation frequencies in Charcot–Marie–Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study" Eur J Hum Genet (1996) 10.1159/000472166

[17]

Dubourg "The frequency of 17p11.2 duplication and Connexin 32 mutations in 282 Charcot–Marie–Tooth families in relation to the mode of inheritance and motor nerve conduction velocity" Neuromuscul Disord (2001) 10.1016/s0960-8966(00)00222-4

[18]

Boerkoel "Charcot–Marie–Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation" Ann Neurol (2002) 10.1002/ana.10089

[19]

Szigeti "Charcot–Marie–Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management" Genet Med (2006) 10.1097/01.gim.0000200160.29385.73

[20]

Verhoeven "MFN2 mutation distribution and genotype/phenotype correlation in Charcot–Marie–Tooth type 2" Brain (2006) 10.1093/brain/awl126

[21]

Ouvrier "Autosomal-recessive and X-linked forms of hereditary motor and sensory neuropathy in childhood" Muscle Nerve (2007) 10.1002/mus.20776

[22]

Vallat "Autosomal-recessive Charcot–Marie–Tooth diseases" J Neuropathol Exp Neurol (2005) 10.1093/jnen/64.5.363

[23]

Lupski "Hereditary motor and sensory neuropathies involving altered dosage or mutation of PMP22: the CMT1A duplication and HNPP deletion" (2005)

[24]

Hoogendijk "De-novo mutation in hereditary motor and sensory neuropathy type I" Lancet (1992) 10.1016/0140-6736(92)90668-s

[25]

Lewis "Electrophysiological features of inherited demyelinating neuropathies: a reappraisal in the era of molecular diagnosis" Muscle Nerve (2000) 10.1002/1097-4598(200010)23:10<1472::aid-mus3>3.0.co;2-#

[26]

Dubourg "Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot–Marie–Tooth disease" Brain (2001) 10.1093/brain/124.10.1958

[27]

Street "Charcot–Marie–Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes" Neuromuscul Disord (2002) 10.1016/s0960-8966(02)00021-4

[28]

Suter "Phosphoinositides and Charcot–Marie–Tooth disease: new keys to old questions" Cell Mol Life Sci (2007) 10.1007/s00018-007-7381-7

[29]

Schröder "Neuropathology of Charcot–Marie–Tooth and related disorders" Neuromolecular Med (2006) 10.1385/nmm:8:1:23

[30]

Pareyson "Differential diagnosis of Charcot–Marie–Tooth disease and related neuropathies" Neurol Sci (2004) 10.1007/s10072-004-0233-4

[31]

Dyck "Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1" Neurology (1989) 10.1212/wnl.39.10.1302

[32]

Hoogendijk "Hereditary motor and sensory neuropathy type I: clinical and neurographical features of the 17p duplication subtype" Muscle Nerve (1994) 10.1002/mus.880170112

[33]

Birouk "Charcot–Marie–Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases" Brain (1997) 10.1093/brain/120.5.813

[34]

Thomas "The phenotypic manifestations of chromosome 17p11.2 duplication" Brain (1997) 10.1093/brain/120.3.465

[35]

Hattori "Demyelinating and axonal features of Charcot–Marie–Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients" Brain (2003) 10.1093/brain/awg012

[36]

Verhamme "Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy IA" J Neurol (2004) 10.1007/s00415-004-0578-x

[37]

Carvalho "Charcot–Marie–Tooth disease type 1A: clinicopathological correlations in 24 patients" J Peripher Nerv Syst (2005) 10.1111/j.1085-9489.2005.10112.x

[38]

Bienfait "Comparison of CMT1A and CMT2: similarities and differences" J Neurol (2006) 10.1007/s00415-006-0260-6

[39]

Burns "Evolution of foot and ankle manifestations in children with CMT1A" Muscle Nerve (2009) 10.1002/mus.21140

[40]

Killian "Longitudinal studies of the duplication form of Charcot–Marie–Tooth polyneuropathy" Muscle Nerve (1996) 10.1002/(sici)1097-4598(199601)19:1<74::aid-mus10>3.0.co;2-3

[41]

Garcia "Charcot–Marie–Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study" Neurology (1998) 10.1212/wnl.50.4.1061

[42]

Berciano "Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot–Marie–Tooth disease 1A duplication" Neuromuscul Disord (2000) 10.1016/s0960-8966(99)00114-5

[43]

Berciano "Initial semeiology in children with Charcot–Marie–Tooth disease 1A duplication" Muscle Nerve (2003) 10.1002/mus.10299

[44]

Padua "Natural history of CMT1A including QoL: a 2-year prospective study" Neuromuscul Disord (2008) 10.1016/j.nmd.2007.11.008

[45]

Shy "Neuropathy progression in Charcot–Marie–Tooth disease type 1A" Neurology (2008) 10.1212/01.wnl.0000297553.36441.ce

[46]

Berciano "Charcot–Marie–Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study" J Neurol Neurosurg Psychiatry (2006) 10.1136/jnnp.2006.093443

[47]

Garcia "Clinical variability in two pairs of identical twins with the Charcot–Marie–Tooth disease type 1A duplication" Neurology (1995) 10.1212/wnl.45.11.2090

[48]

Burns "Hand involvement in children with Charcot–Marie–Tooth disease type 1A" Neuromuscul Disord (2008) 10.1016/j.nmd.2008.08.004

[49]

Yiu "Neurophysiologic abnormalities in children with Charcot–Marie–Tooth disease type 1A" J Peripher Nerv Syst (2008) 10.1111/j.1529-8027.2008.00182.x

[50]

Kaku "Nerve conduction studies in Charcot–Marie–Tooth polyneuropathy associated with a segmental duplication of chromosome 17" Neurology (1993) 10.1212/wnl.43.9.1806

Showing 50 of 121 references

Cited By

508

Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models

Mafalda Rizzuti, Elisa Pagliari · 2025

Stem Cell Reports

Telecoaching: a potential new training model for Charcot-Marie-Tooth patients: a systematic review

Ignazio Leale, Vincenzo Di Stefano · 2024

Frontiers in Neurology

Physical Activity in Patients with Neuromuscular Disease Three Years after COVID-19, a Longitudinal Survey: The After-Effects of the Quarantine and the Benefits of a Return to a Healthier Life-Style

Ignazio Leale, Valerio Giustino · 2024

Journal of Clinical Medicine

Autoimmune Autonomic Neuropathy: From Pathogenesis to Diagnosis

Shunya Nakane, Haruki Koike · 2024

International Journal of Molecular...

A meta-analysis on the prevalence of Charcot–Marie–Tooth disease and related inherited peripheral neuropathies

Miaomiao Ma, Yao Li · 2023

Journal of Neurology

Identification and functional characterization of novel GDAP1 variants in Chinese patients with Charcot–Marie–Tooth disease

Cong‐Xin Chen, Jia‐Qi Li · 2020

Annals of Clinical and Translationa...

Genetic epidemiology of Charcot-Marie-Tooth disease

G. J. Braathen · 2012

Acta Neurologica Scandinavica

Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies

Patrick Yu-Wai-Man, Philip G. Griffiths · 2011

Progress in Retinal and Eye Researc...

Metrics

508

Citations

121

References

Details

Published: Jul 01, 2009
Vol/Issue: 8(7)
Pages: 654-667
License: View

Authors

D

Davide Pareyson

From the MRC Centre for Neuromuscular Diseases (P.J.T., A.M.R., A.H., A.C., M.L., M.M.R.), Department of Neuropathology (Z.J.), and Department of Neurogenetics (R.P., J.P., H.H.), National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, Queen Square, London, UK; Clinic of Central and Peripheral Degenerative Neuropathies Unit (P.S., G.P., D.P.), Department of Clinical Neurosciences, IRCCS Foundation, C. Besta Neurological Institute, Milan, Italy; Department of Clinical...

C

Chiara Marchesi

Cite This Article

Davide Pareyson, Chiara Marchesi (2009). Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. The Lancet Neurology, 8(7), 654-667. https://doi.org/10.1016/s1474-4422(09)70110-3

Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

You May Also Like